{"created":"2023-06-19T10:41:21.139456+00:00","id":1014,"links":{},"metadata":{"_buckets":{"deposit":"8891f139-a7b6-43b1-9008-e90cbc474a28"},"_deposit":{"created_by":3,"id":"1014","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"1014"},"status":"published"},"_oai":{"id":"oai:shiga-med.repo.nii.ac.jp:00001014","sets":["10:11:338"]},"author_link":["2267"],"item_2_alternative_title_18":{"attribute_name":"その他の言語のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"クロミプラミンとその水酸化代謝物および脱メチル化代謝物の血漿中濃度の臨床的意義 ： 治療的薬物モニタリングデータを用いた判別分析による気分障害の治療効果の予測"},{"subitem_alternative_title":"クロミプラミン ト ソノ スイサンカ タイシャブツ オヨビ ダツメチルカ タイシャブツ ノ ケッショウチュウ ノウド ノ リンショウテキ イギ ： チリョウテキ ヤクブツ モニタリング データ ヲ モチイタ ハンベツ ブンセキ ニ ヨル キブン ショウガイ ノ チリョウ コウカ ノ ヨソク"}]},"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1994-03-24","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{}]}]},"item_2_description_42":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"Others","subitem_description_type":"Other"}]},"item_2_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"学位授与機関：　滋賀医科大学　博士（医学）第164号　平成6年3月24日","subitem_description_type":"Other"},{"subitem_description":"Journal of Affective Disorders. 1993, 29(4), p.267-279.","subitem_description_type":"Other"}]},"item_2_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"滋賀医科大学"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"野口, 俊文"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-02-16"}],"displaytype":"detail","filename":"h164.pdf","filesize":[{"value":"2.4 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"h164.pdf","url":"https://shiga-med.repo.nii.ac.jp/record/1014/files/h164.pdf"},"version_id":"96c8eb3a-a398-41b6-8ae5-3f6626b7b0a0"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites : prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites : prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data."}]},"item_type_id":"2","owner":"3","path":["338"],"pubdate":{"attribute_name":"公開日","attribute_value":"2012-11-27"},"publish_date":"2012-11-27","publish_status":"0","recid":"1014","relation_version_is_last":true,"title":["Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites : prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data."],"weko_creator_id":"3","weko_shared_id":3},"updated":"2023-06-19T11:26:32.318279+00:00"}